Sageworth Trust CO Catalent, Inc. Transaction History

Sageworth Trust CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 06, 2022	SELL	$94.19 - $124.49 $14,128 - $18,673	-150 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$119.57 - $139.07 $59,785 - $69,535	-500 Reduced 76.92%	150 $19,000
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $65,221 - $75,198	650 New	650 $70,000
Q2 2019 Jul 19, 2019	SELL	$39.26 - $54.21 $30,976 - $42,771	-789 Closed	0 $0
Q1 2019 Apr 08, 2019	BUY	$29.84 - $43.92 $23,543 - $34,652	789 New	789 $32,000

484

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Sageworth Trust CO, based on Form 13F filings with the SEC.

Stay updated on Sageworth Trust CO with notifications on news.